BFM
MRK icon

Boothbay Fund Management’s Merck MRK Stock Holding History

Boothbay Fund Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,100
Closed -$4.01M – 2379
2022
Q4 		$4.01M Buy
36,100
+31,000
+608% +$3.17M 0.09% 309
2022
Q3 		$439K Sell
5,100
-122,000
-96% -$10.9M 0.01% 1296
2022
Q2 		$11.6M Buy
127,100
+116,800
+1,134% +$10.4M 0.31% 36
2022
Q1 		$845K Buy
+10,300
New +$812K 0.02% 1006
2021
Q4 		– Sell
-585,800
Closed -$44M – 2097
2021
Q3 		$44M Buy
+585,800
New +$44.6M 1.22% 3
2019
Q4 		– Sell
-201
Closed -$1.62M – 935
2019
Q3 		$1.62M Buy
+201
New +$16.1K 0.15% 191
2018
Q3 		– Sell
-330
Closed -$1.91M – 889
2018
Q2 		$1.91M Buy
+330
New +$18.6K 0.17% 105

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boothbay Fund Management's MRK Position: Q2 2026 in Review

Boothbay Fund Management sold out of Merck (MRK) in Q2 2026, closing a stake of 25,244 shares — an estimated $3.04M sold.

Boothbay Fund Management first reported a position in MRK in Q1 2015 and held it in 32 quarters. The position peaked at $23.5M in Q1 2023. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Boothbay Fund Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 25,244 Merck shares in Q2 2026, an estimated $3.04M.
  • Boothbay Fund Management first reported a position in Merck in Q1 2015 and held it in 32 quarters.
  • Boothbay Fund Management's Merck position peaked at $23.5M in Q1 2023.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.